Jill Henrich - Mar 4, 2024 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
EVP, Global Head RA & Quality
Signature
/s/ John Chao, Attorney-in-Fact for Jill Henrich
Stock symbol
ATRA
Transactions as of
Mar 4, 2024
Transactions value $
-$2,793
Form type
4
Date filed
3/6/2024, 06:16 PM
Previous filing
Jan 9, 2024
Next filing
May 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale -$2.79K -3.88K -0.69% $0.72 555K Mar 4, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
F2 The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 4, 2024 and March 5, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.